NATCO Receives CDSCO Approval For Semaglutide In India
16 Feb 2026 //
INDPHARMAPOST
SFDA Approves OneSource`s Generic Semaglutide in Saudi Arabia
11 Feb 2026 //
EXPRESSPHARMA
Meijer Announces New Affordable Access To GLP-1 Medications
10 Feb 2026 //
PR NEWSWIRE
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
Astrazeneca`s Oral GLP-1 Scored Phase 2 Wins, But No Data Yet
10 Feb 2026 //
FIERCE BIOTECH
Novo Nordisk Sues Hims & Hers Over Counterfeit Wegovy®
09 Feb 2026 //
GLOBENEWSWIRE
Hims to stop offering GLP-1 pill after FDA warned of crackdown
09 Feb 2026 //
REUTERS
Novo Nordisk Launches Wegovy® Pill For Consumers At Major Event
06 Feb 2026 //
PR NEWSWIRE
FDA Commissioner Pledges Crackdown On Compounding Practices
06 Feb 2026 //
FIERCE PHARMA
Hims & Hers Launches $49/Month Weight Loss Compound
05 Feb 2026 //
PHARMIWEB
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Addresses Hims & Hers` Illegal Compounding
05 Feb 2026 //
GLOBENEWSWIRE
Publix Pharmacy Provides Savings On Certain GLP-1 Medications
03 Feb 2026 //
BUSINESSWIRE
Skye Reports Positive Cbeyond Ph 2A Extension Interim Study
02 Feb 2026 //
GLOBENEWSWIRE
Novo`s next-gen obesity drug outperforms Wegovy in diabetes trial
02 Feb 2026 //
REUTERS
Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study
02 Feb 2026 //
FIERCE BIOTECH
LIR Life Sciences: Positive CPP Transdermal GLP/GIP Data Reported
29 Jan 2026 //
ACCESSWIRE
Sun Pharma Receives DCGI Approval For Generic Semaglutide
23 Jan 2026 //
ECONOMICTIMES
Wegovy Pill Launch Wows With Strong Early Uptake: Analysts
23 Jan 2026 //
FIERCE PHARMA
Novo`s Wegovy pill hits over 18,000 US prescriptions in Debut
23 Jan 2026 //
REUTERS
Sesame Launches Wegovy Pill Through Collaboration With Novo
22 Jan 2026 //
BUSINESSWIRE
Lupin, Galenicum Sign Semaglutide Deal In 23 Countries
22 Jan 2026 //
PRESS RELEASE
CoreAge Rx Expands GLP-1 Access For New Year Weight Loss Goals
20 Jan 2026 //
PR NEWSWIRE
Novo Riffs On Apple`s `Get A Mac` Ads In New Ozempic Push
20 Jan 2026 //
FIERCE PHARMA
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
Novo Boosted As Oral Wegovy Reaches 3,000 Patients In Debut Week
19 Jan 2026 //
BIOSPACE
BoomRx Launches Oral Semaglutide & Tirzepatide Nationwide
14 Jan 2026 //
PR NEWSWIRE
Novo Refocuses On Diabetes & Obesity, Expanding GLP-1 Market
14 Jan 2026 //
BIOSPACE
US FDA Requests Removal of Suicide Warnings From Weight-loss Drug
13 Jan 2026 //
REUTERS
2026 Analysis Examines Wegovy Pill Access and Cash-Pay Options
12 Jan 2026 //
GLOBENEWSWIRE
Ro.Co Analyzes 2026 FDA Launch Of Wegovy Pill Vs Shot
12 Jan 2026 //
GLOBENEWSWIRE
Canadian Pharma Platform To Provide Indian-Sourced Ozempic
09 Jan 2026 //
ECONOMICTIMES
Amazon Pharma Widens Wegovy Pill Access With Insurance
09 Jan 2026 //
BUSINESSWIRE
MEDVi: Trusted GLP-1 Source for 2026 Telehealth Weight Loss
07 Jan 2026 //
GLOBENEWSWIRE
Enforcement Report - Week of January 7, 2026
07 Jan 2026 //
FDA
Saverxcanada.To Offers Ozempic From India Below U.S. Retail
07 Jan 2026 //
PR NEWSWIRE
EMED Enables WEGOVY PILL ACCESS Via Clinical CARE MODEL
06 Jan 2026 //
PR NEWSWIRE
HC Seeks Novo Nordisk`s Reply On Natco Plea To Revoke Patent
06 Jan 2026 //
ECONOMICTIMES
Novo Nordisk Launches Wegovy Pill, Enhancing Patient Access
05 Jan 2026 //
BUSINESSWIRE
LifMD Expands Novo Nordisk Collaboration For Wegovy Telehealth
05 Jan 2026 //
GLOBENEWSWIRE
GoodRx Offers Cash Prices for Wegovy Pill Launch
05 Jan 2026 //
BUSINESSWIRE
WW Advances Weight Health with Integrated Wegovy Access
05 Jan 2026 //
GLOBENEWSWIRE
Ro Launches Wegovy Pill Through Integration with Novo Nordisk
05 Jan 2026 //
PR NEWSWIRE
Novo launches Wegovy pill in US from $149 per month for patients
05 Jan 2026 //
REUTERS
Novo`s GLP-1 Failure Sparks Alzheimer`s Combination Opportunity
02 Jan 2026 //
BIOSPACE
China`s Top Court Upholds Novo Nordisk Semaglutide Patent
31 Dec 2025 //
GLOBENEWSWIRE
Novo and Lilly Cut Prices of Weight-Loss Drugs in China
29 Dec 2025 //
REUTERS
Industry Eyes 2026 GLP-1 Compounding, Telehealth Pricing
26 Dec 2025 //
GLOBENEWSWIRE
Biocon Signs Out-Licensing Deal For Semaglutide With Ajanta
23 Dec 2025 //
INDPHARMAPOST
FDA Approves Novo Nordisk`s Wegovy Pill For Adult Weight Loss
23 Dec 2025 //
PR NEWSWIRE
Novo Nordisk’s Wegovy Receives Approval in US
22 Dec 2025 //
FDA
Emcure Launches Poviztra Semaglutide Injection In India
22 Dec 2025 //
EXPRESSPHARMA
Novo Files Marketing Application For Next-gen Weight-Loss Drug
22 Dec 2025 //
REUTERS
Protheragen Tackles FDA Drug Shortages with GLP-1 API Expansion
19 Dec 2025 //
PHARMIWEB
SkinnyRx Beats 2026 GLP-1 Prices: $199/Month Semaglutide
18 Dec 2025 //
GLOBENEWSWIRE
Novo`s Oral Semaglutide Is PCPs` Most-Anticipated Obesity Med
15 Dec 2025 //
FIERCE PHARMA
Delhi HC Denies Stay On Dr. Reddy`s Export Of Semaglutide
13 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Brings Blockbuster Weight-Loss Drug Ozempic To India
12 Dec 2025 //
ECONOMICTIMES
Novo Nordisk: efficacious dose of Wegovy recommended by theEMA
12 Dec 2025 //
GLOBENEWSWIRE
Delhi HC OKs Sun Pharma`s Export of Proprietary Weight-Loss Drug
10 Dec 2025 //
ECONOMICTIMES

Market Place
Sourcing Support